Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers
- DOI
- 10.3389/fphar.2021.631135
- Published
- 2021-04-16
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2021.631135,
title = {Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers},
author = {Timothy Crook and Darshana Patil and Andrew Gaya and Nicholas Plowman and Sewanti Limaye and Anantbhushan Ranade and Amit Bhatt and Raymond Page and Dadasaheb Akolkar},
year = {2021},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2021.631135},
url = {https://doi.org/10.3389/fphar.2021.631135}
}RIS
TY - JOUR TI - Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers AU - Timothy Crook AU - Darshana Patil AU - Andrew Gaya AU - Nicholas Plowman AU - Sewanti Limaye AU - Anantbhushan Ranade AU - Amit Bhatt AU - Raymond Page AU - Dadasaheb Akolkar PY - 2021 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2021.631135 UR - https://doi.org/10.3389/fphar.2021.631135 ER -
APA
Crook, T., Patil, D., Gaya, A., Plowman, N., Limaye, S., Ranade, A., Bhatt, A., Page, R., & Akolkar, D. (2021). Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.631135
Source records
- crossref · retrieved 2026-09-26T02:35:25.131Z